| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 138 |
| 1 | PREDNISONE | 133 |
| 2 | TACROLIMUS | 133 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 130 |
| 4 | TACROLIMUS OINTMENT 0.1% | 130 |
| 5 | METHOTREXATE SODIUM | 104 |
| 6 | MYCOPHENOLATE MOFETIL | 102 |
| 7 | METHOTREXATE | 97 |
| 8 | METHYLPREDNISOLONE | 88 |
| 9 | PREDNISOLONE | 56 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METHSCOPOLAMINE BROMIDE | 1 | 0.0069 |
| 1 | CEFPODOXIME PROXETIL | 4 | 0.0040 |
| 2 | FAMCICLOVIR | 10 | 0.0036 |
| 3 | DOBUTAMINE | 9 | 0.0024 |
| 4 | DALBAVANCIN HYDROCHLORIDE | 1 | 0.0021 |
| 5 | CISATRACURIUM BESYLATE | 4 | 0.0018 |
| 6 | GANCICLOVIR SODIUM | 19 | 0.0018 |
| 7 | VALGANCICLOVIR | 32 | 0.0017 |
| 8 | LEVOCARNITINE | 6 | 0.0016 |
| 9 | AMPHOTERICIN B | 18 | 0.0014 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 39 | 0.0017 |
| 1 | Carnitine Analog [EPC] | 6 | 0.0016 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 18 | 0.0014 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 27 | 0.0013 |
| 4 | CD33-directed Immunoconjugate [EPC] | 4 | 0.0011 |
| 5 | Osmotic Diuretic [EPC] | 5 | 0.0010 |
| 6 | Nucleoside Analog Antifungal [EPC] | 1 | 0.0007 |
| 7 | Penem Antibacterial [EPC] | 23 | 0.0007 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 11 | 0.0006 |
| 9 | Lipopeptide Antibacterial [EPC] | 5 | 0.0005 |